Related Experiment Video
Updated: Sep 3, 2025
12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
14.2K
Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD)
Eslam Shosha1, Salman A Aljarallah2, Norah Al Fugham3
1Division of Neurology, Department of Medicine, McMaster University, HHSC, Hamilton, ON, Canada.
Multiple Sclerosis and Related Disorders
|July 31, 2022
Summary
Neuromyelitis optica spectrum disorder (NMOSD) diagnosis and management are improving with new criteria and therapies. Aquaporin-4 (AQP4) antibodies are key biomarkers, though AQP4-negative cases remain challenging.
Area of Science:
- Neuroimmunology
- Neurology
- Autoimmune Diseases
Background:
- Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune demyelinating disease affecting the optic nerves and spinal cord.
- Symptoms range from mild motor impairment to paralysis, significantly impacting patient quality of life.
Purpose of the Study:
- To review recent advancements in NMOSD diagnosis and management.
- To highlight the significance of aquaporin-4 (AQP4) antibodies in NMOSD.
- To discuss emerging therapeutic strategies and challenges in AQP4-negative NMOSD.
Main Methods:
- Review of recent literature on NMOSD diagnosis and treatment.
- Analysis of the role of AQP4 antibodies as diagnostic biomarkers.
- Evaluation of novel immunomodulatory and targeted therapies.
Main Results:
- New diagnostic criteria enhance NMOSD diagnostic accuracy.
- Emerging therapies target key inflammatory pathways including IL-6, complement, and B cells.
- Aquaporin-4 (AQP4) antibody testing is a crucial biomarker for NMOSD.
Conclusions:
- NMOSD diagnosis and management are rapidly evolving with improved accuracy and novel treatment options.
- Targeted therapies offer new hope, but AQP4-negative NMOSD presents ongoing management challenges.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
01:26Nephrotic Syndrome II : Assessment and Medical Management
20
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
20
01:24Nephrotic Syndrome III : Nursing Management
40
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
40
01:21Rheumatic Heart Disease III: Medical Management
29
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
01:14Myocarditis III: Medical Management
14
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
01:27Open Angle Glaucoma: Treatment
535
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
535